| __timestamp | Dr. Reddy's Laboratories Limited | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 38783000000 | 22570000 |
| Thursday, January 1, 2015 | 42585000000 | 24378000 |
| Friday, January 1, 2016 | 45702000000 | 26621000 |
| Sunday, January 1, 2017 | 46372000000 | 28653000 |
| Monday, January 1, 2018 | 46910000000 | 37734000 |
| Tuesday, January 1, 2019 | 48890000000 | 41884000 |
| Wednesday, January 1, 2020 | 50129000000 | 64435000 |
| Friday, January 1, 2021 | 54559000000 | 57483000 |
| Saturday, January 1, 2022 | 62081000000 | 70062000 |
| Sunday, January 1, 2023 | 105931000000 | 52790000 |
| Monday, January 1, 2024 | 77201000000 |
Igniting the spark of knowledge
In the world of pharmaceuticals, strategic spending on Selling, General, and Administrative (SG&A) expenses can be a key differentiator. Dr. Reddy's Laboratories Limited and Ligand Pharmaceuticals Incorporated offer a fascinating study in contrasts. Over the past decade, Dr. Reddy's has seen a steady increase in SG&A expenses, peaking in 2023 with a staggering 105% increase from 2014. This growth reflects their aggressive market expansion and investment in global operations.
Conversely, Ligand Pharmaceuticals has maintained a more conservative approach, with SG&A expenses growing by approximately 210% over the same period. This restrained spending aligns with their niche focus on drug discovery and licensing. Notably, data for 2024 is incomplete, highlighting the dynamic nature of financial reporting. As these companies navigate the ever-evolving pharmaceutical landscape, their SG&A strategies will continue to shape their competitive positions.
Comparing SG&A Expenses: Takeda Pharmaceutical Company Limited vs Ligand Pharmaceuticals Incorporated Trends and Insights
Comparing SG&A Expenses: Biogen Inc. vs Dr. Reddy's Laboratories Limited Trends and Insights
Breaking Down SG&A Expenses: Dr. Reddy's Laboratories Limited vs Jazz Pharmaceuticals plc
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Xenon Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of Dr. Reddy's Laboratories Limited and Taro Pharmaceutical Industries Ltd.
Breaking Down SG&A Expenses: Apellis Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated
Operational Costs Compared: SG&A Analysis of Viking Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated
Who Optimizes SG&A Costs Better? Xenon Pharmaceuticals Inc. or Ligand Pharmaceuticals Incorporated
Breaking Down SG&A Expenses: Merus N.V. vs Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated vs Dynavax Technologies Corporation: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Ligand Pharmaceuticals Incorporated or Galapagos NV